Moleculin Biotech (MBRX) announced new findings supporting the ability of Annamycin to overcome resistance to Venetoclax in acute myeloid leukemia. This includes data from preclinical in vitro studies ...

“Patients treated with the venetoclax-obinutuzumab combination showed a statistically significant sustained prolongation of PFS compared with patients treated with chlorambucil-obinutuzumab (76. ...

A new research paper titled "ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity ... Cleavage of Caspase 3, PARP1 and HSP90, as well as increased Annexin V positivity, suggests potent ...